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A critical question raised by the initial observations in guinea pigs (1)  and in the 
studies in mice presented in the preceding paper (2) is that of the precise role of the 
host T cell in the mediation of the allogeneic effect on antibody production. Thus, the 
phenomenon requires the existence of an active graft-versus-host  (GVH) 1 reaction in 
which the primed B lymphocytes are those of the host cell population. The occurrence 
of a host rejection reaction is not only not required, but also appears to play little,  if 
any, role (1, 3). This suggests that, by direct action on primed B cells,  the allogeneic 
effect obviates entirely the need for the interaction between isologous T and B lympho- 
cytes specific for the challenging conjugate, or, alternatively, enhances the functional 
effectiveness of the small number of isologous T  cells  specific  for the second carrier. 
To approach this issue directly requires a  system in which both cell popula- 
tions,  i.e.  the  2,4-dinotrophenyl  (DNP)-primed  population  and  a  population 
of allogeneic lymphoid cells,  are accessible to experimental  manipulation  such 
that the T  lymphocytes of one or the other can be selectively removed. In the 
present study, we describe  conditions for the elicitation of an allogeneic effect 
on  the  adoptive  transfer  secondary  anti-DNP  antibody  response  in  mice. 
Utilizing such a  model, we have established  that the allogeneic effect on anti- 
body production can operate on a population of primed B  lymphocytes which 
have been depleted of their isologous T  lymphocytes. 
Materials and Methods 
The proteins  and hapten-carrier  conjugates were identical  to those described in the pre- 
ceding paper  (2). 
* This  investigation was  supported  by Grant AI-10630 from the National  Institutes  of 
Health,  U.S. Public Health Service. 
:~ Supported by Surgical Training Grant GM-2019 from the National Institutes of Health, 
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1 Abbreviations used in this paper: BGG, bovine gamma globulin; CFA, complete Freund's 
adjuvant; D-GL, copolymer of D-glutamic acid and D-lysine; DNP, 2,4-dinitrophenyl;  GVH, 
graft-versus-host;  KLH,  keyhole  limpet  hemocyanin;  MEM,  Eagle's  minimum  essential 
medium. 
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Animals.--Mice of the inbred strains BALB/c, C57BL/6N,  AKR, and C3H/HeN were 
obtained from the Jackson Laboratory, Bar Harbor, Maine. Certain BALB/c mice were also 
obtained from West Seneca Laboratories, Buffalo,  N.Y. 
Adoptive  Transfer  Svstem.--The  basic scheme followed  is  diagrammatically  outlined in 
Fig. 1. lVIale BALB/c mice, 8-12 wk of age, received primary immunization with 100/~g  of 
DNPg-keyhole limpet hemocyanln (KLH) emulsified  in complete Freund's adjuvant (CFA) 
intraperitoneally. 2 wk later, these DNP-KLH-prlmed mice were killed  and their spleens re- 
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FIG. 1.  Model II: transfer of DNP-primed syngeneic and nonprimed allogeneic  lymphoid 
cells into irradiated host. Experimental protocol for elicitation of the allogeneic effect on  the 
adoptive transfer secondary anti-DNP response. See Materials and Methods for explanation. 
moved. Single cell suspensions in minimal essential medium (MEM)  (Eagle)  were prepared, 
washed, and transferred intravenously to syngeneic, irradiated  (450 R)  BALB/c recipients. 
Preliminary experiments established that a  dose of 25  X  106  DNP-KLH-primed nucleated 
cells was optimal for conditions of these studies and was therefore used throughout. 24 hr 
after transfer of the DNP-KLH-primed cells, a second intravenous cell transfer consisting of 
varying numbers of splenic lymphoid cells from nonimmune allogeneic C57BL/6N donors was 
performed in  certain  recipient mice.  Control  recipients did  not  receive an  allogeneic  cell 
transfer. 1 day after the second cell transfer mice were either subjected to a secondary challenge 
intraperitoneally with an aqueous DNP-carrier conjugate or were not secondarily immunized. 
All mice were bled 7 days after challenge from the retroorbital plexus and serum anti-DNP 
antibody levels were determined as described previously (4). 
Preparation  of Anti-O Serum.--Anti-OC3H  serum was prepared according to the general 
scheme described by Reif and Allen  (5). Briefly, thymocytes were obtained from 4-6-wk old 
C3H/HeN mice and injected intraperitoneally at a  (lose of  100  X  106 cells into individual 
AKR male mice.  1 and 2 wk after the last of six consecutive weekly immunizations, all mice DAVID  IY.  ICATZ AND  DAVID  P.  OSBORNE~  JR.  457 
were bled and the sera pooled. 1 wk thereafter  all mice received a final injection of C3H 
thymocytes and were bled again 7 days later. 
, t e Determination of A nti-O Serum Cytotoxicity.--Cytotoxicity of the heat-inactivated  (56°C  for 
30 min) anti-0 sera was measured by a method utilizing chromium-51 release as the index of 
cytolysis in the presence of appropriately diluted guinea pig complement. This procedure has 
been described in detail by Stobo et al. (6). The anti-0 sera employed lysed 90-95% of thymo- 
cytes (C3H or BALB/c) at a 1  : 100 dilution and 30--40% of splenic lymphocytes at a 1:9-1:27 
dilution. 
Anti-O  Serum  Treatment  of DNP-KLtt-Primed  Splenic  Lymphocytes.--Single  spleen cell 
suspensions were treated with anti-0 serum and complement as follows: BALB/c spleen cells 
were suspended in 10% calf serum-supplemented MEM at a concentration of 100 ×  106 cells 
per 0.5 ml. 0.34?.5 ml of heat-inactivated  anti-0C3H was added to each such sample and the 
mixture incubated at 4°C for 30 min, washed, and then resuspended in 0.5 ml of medium. 
1.0 ml of guinea pig complement (diluted 1:2 in medium) was added to each portion and the 
mixture incubated for an additional 40 min at 37°C. After thorough washing, remaining cells 
were resuspended in the  appropriate  volume of MEM  and then transferred  to irradiated 
recipients intravenously. Viability of recovered cells was 89-97%  by dye exclusion (trypan 
blue) and the usual total recovery of viable cells after such treatment was in the range of 55%. 
RESULTS 
The Allogeneic Effect on the Adoptive  Transfer Secondary Anti-DNP Response.--Following 
the scheme outlined in Materials and Methods  (Fig. 1), 25 X  10  a spleen cells from DNP- 
KLH-primed  BALB/c  donor  mice were injected  intravenously  into irradiated  syngeneic 
BALB/c recipients. 24 hr later, groups of these recipients were injected with varying numbers 
of allogeneic cells from nonimmunized C57BL donors; groups of control mice received no 
allogeneic cells. 1 day after the second cell transfer (48 hr after initial adoptive transfer) the 
recipients were challenged with 10 ug of DNP-KLH or 50 #g of DNP bovine gamma globulin 
(BGG) intraperitoneally,  or  not secondarily challenged. All mice were bled  7 days  after 
secondary challenge. 
The results are illustrated graphically in Fig. 2.  Recipients of DNP-KLH- 
primed syngeneic cells but no additional allogeneic cells manifested sharp adop- 
tive secondary anti-DNP responses  to  the  homologous antigen, DNP-KLH, 
but failed to produce  appreciable quantities of  antibody to  a  challenge with 
DNP-BGG. In contrast,  recipients of DNP-primed cells which were  also in- 
jected with allogeneic cells developed secondary responses to DNP-BGG that 
were related in magnitude to the number of allogeneic cells administered. Thus, 
the dose of 2.5  X  106 cells (an allogeneic-to-primed cell ratio of 1:10) elicited 
the  optimal effect.  5  X  l06 allogeneic cells resulted in a  significant enhance- 
ment over control responses, though not as great as that obtained with 2.5  X 
10 ~ cells, while 1  X  106 cells produced only a  slight increase in response over 
controls. All mice in an experimental group which received 10 X  10  ~ allogeneic 
cells died before the 7 day bleeding, presumably as a result of the intense GVH 
reaction. 
Elicitation of the Allogeneic Effect on DNP-Primed Cells Depleted of Isologous 
T  Lymphocytes.--With  the demonstration in the preceding experiment that an 
allogeneic effect could be elicited in a suitable adoptive transfer model, a study 
could be made of the requirement of host T  cells, i.e. those T lynlphocytes isolo- 458  CELL  INTERACTIONS  IN  ALLOGENEIC  EFFECT 
gous  to  the DNP-primed  B  ceils in  the system,  for  the  expression  of the phe- 
nomenon.  In order  to  accomplish  this,  experiments  were performed,  using  the 
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The  allogeneic  effect on  the  adoptive  transfer  secondary  anti-DNP  antibody 
response.  25  X  106 spleen cells from BALB/c donor mice, primed 2 wk previously with 100 
#g  of DNP-KLH emulsified in CFA, were injected intravenously into irradiated  syngeneic 
BALB/c recipients. 24 hr later, groups of these recipients were injected intravenously with 
varying numbers of allogeneic spleen cells from nonimmunized C57BL donors; groups of con- 
trol mice (open bars)  did not receive allogeneic cells.  1 day after the second cell transfer, the 
recipients were either not challenged or secondarily challenged with 10 #g of DNP-KLH or 
50 #g of DNP-BGG intraperitoneally. The geometric mean levels of serum anti-DNP antibody 
of groups of five mice bled 7 days after secondary challenge are illustrated. A comparison of 
the recipients of allogeneic cells secondarily challenged with DNP-BGG with the control group 
also challenged with DNP-BGG yielded P  values as shown. 
optimal  conditions  established  in  the  preceding  experiment,  in  which  a  com- 
parison was made of the capacity to elicit the allogeneic effect on DNP-primed 
ceils which had or had  not been depleted of their isologous T  lymphocytes. 
Spleen  cells  from  DNP-KLH-primed BALB/c were  either  treated  in  vitro with  anti-e 
serum plus complement or not treated and  then injected intravenously into irradiated  syn- DAVID  H. KATZ  AND  DAVID  P. OSBORNE~  JR.  459 
geneic BALB/c recipients. Each recipient was injected with 25 X  106 untreated or  anti-#- 
treated cells. 24 hr after the first cell transfer, groups of recipients of each cell type (untreated 
or anti-# treated) were injected intravenously with 2.5  X  106 allogeneic C57BL spleen  cells 
while corresponding control groups received no allogeneic cell transfer. 1 day later, mice were 
secondarily challenged with either 10  /~g of DNP-KLH  or 50 /~g of DNP-BGG  intraperi- 
toneally, or not challenged. All mice were bled 7 days after secondary immunization. 
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FIo. 3.  Elicitation of the allogeneic effect on DNP-KLH-primed cells depleted of isologous 
T  lymphocytes. Spleen cells from BALB/c donors, primed 2 wk earlier with 100/zg of DNP- 
KLH in CFA, were either treated in vitro with anti-0 serum plus complement or not treated 
and then injected intravenously (25  X  106 cells/recipient) into irradiated syngeneie BALB/c 
recipients. 24 hr later, groups of recipients of each cell type (untreated or anti-0 treated) were 
injected intravenously with 2.5  Y  l0  s allogeneic C57BL spleen cells.  Corresponding control 
groups received no allogeneic cell transfer.  1 day after the second cell transfer~ mice were 
secondarily challenged with either 10 #g of DNP-KLH or 50 #g of DNP-BGG intraperitone- 
ally, or not challenged. The geometric mean levels of serum anti-DNP antibody of groups of 
five mice bled 7 days after secondary challenge are illustrated. Statistical comparisons of the 
recipients of  DNP-KLH  cells  challenged with DNP-BGG  gave the following results.  Com- 
parison of allogeneic cell recipients with controls yielded a  P  value of 0.10  >  P  >  0.05 for 
anti-P-treated cells. Comparison of allogeneic cell recipients of anti-P-treated cells secondarily 
challenged with DNP-BGG with recipients of anti-P-treated cells not given allogeneic cells 
and secondarily challenged with DNP-KLH yielded a P  value of 0.05 >  P  >  0.025. 460  CELL  INTERACTIONS  IN  ALLOGENEIC  EFFECT 
As depicted graphically in Fig. 3, recipients of syngeneic DNP-primed spleen 
cells which were not subjected to anti-0 treatment produced, as expected, high 
levels of anti-DNP  antibody after secondary challenge with DNP-KLH irre- 
spective of whether or not they received a  second transfer of allogeneic cells. 
On  the other hand,  recipients of untreated DNP-primed cells alone failed to 
respond to DNP-BGG, whereas a  significantly enhanced  anti-DNP  response 
to DNP-BGG was  obtained in  those  recipients  also injected with  allogeneic 
lymphoid cells.  Treatment of the DNP-primed cells with anti-0 plus comple- 
ment  in  vitro before adoptive  transfer  abolished  the  secondary response  to 
DNP-KLH in  those mice which did not also receive allogeneic cells.  In con- 
trast,  recipients  of anti-0-treated DNP-primed  cells  plus  allogeneic cells  dis- 
played clearly enhanced anti-DNP antibody responses both to DNP-KLH and 
DNP-BGG. The highest responses were obtained after secondary challenge to 
DNP-BGG and it is particularly noteworthy that the magnitude of the allo- 
geneic effect on the anti-0-treated population in response to the latter conju- 
gate was comparable in magnitude to that obtained with the untreated DNP- 
primed cells.  The finding that the responses to DNP-BGG were greater than 
those  obtained  with  the  homologous  antigen,  DNP-KLH,  in  these  circum- 
stances probably reflects the fact that the molar concentration of DNP admin- 
istered was roughly 30-fold greater in the case of DNP-BGG as compared with 
DNP-KLH. Comparable observations were obtained in an essentially identicM 
experiment in which control DNP-KLH-primed cells were treated with normal 
mouse serum plus complement in vitro before adoptive transfer. These results 
strongly  indicate,  therefore,  that  the  participation  of  host  (or  isologous)  T 
lymphocytes is not required for the expression of the Mlogeneic effect phenome- 
non on antibody production. 
DISCUSSION 
It is now well established that under appropriate conditions the GVH reac- 
tion may greatly enhance antibody production to a variety of antigens both in 
vivo (1-3, 7, 7a) and in vitro (7a, 8, 9). In antibody responses to hapten-carrier 
conjugates, evidence has been presented that the allogeneic effect replaces the 
requirement for carrier-specific helper T  cells  normally participating  in  such 
immune reactions 0-3, 7, 7a). This latter point could result from the allogeneic 
effect acting either: (a)  to heighten stimulation and/or increase the functional 
efficiency of the small numbers of helper T  cells specific for the carrier in ques- 
tion that presmnably exist in the virgin population; or (b)  to create a  critical 
alteration, either in milieu or in the cell itself, that permits the specific B lym- 
phocyte to respond to the antigenic stimulus, with or without the participation 
of isologous T  lymphocytes. 
In  its fullest consideration, the  allogeneic effect may involve a  number of 
cell interactions between and among donor and host lymphocytes. These poten- 
tial interactions are illustrated schematically in Fig. 4 in which cell populations DAVID  H.  KATZ  AND  DAVID  P.  OSBORNE,  JR.  461 
are identified as unprimed and DNP primed (analogous, respectively, to donor 
and host cells  in  the  classical in vivo model)  to facilitate adaptation of the 
scheme to adoptive transfer or in vitro systems. Disregarding the theoretical 
interaction  between  the  two  B  cell  populations,  there  are  five  interactions 
potentially occurring after mixture of two allogeneic populations: I,  II,  and 
IV involve mixed lymphocyte interactions based on surface histocompatibility 
antigens, whereas  III  and V  represent  the  interactions between isologous T 
and B lymphocytes. It is now possible to dissect this scheme in the context of 
the allogeneic effect phenomenon on antibody production as follows. 
Firstly, we can essentially disregard the interactions IV and V in this scheme 
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since it has been previously demonstrated that antibody is produced solely by 
B  lymphocytes of the primed  cell  population (3).  Thus,  although IV  and V 
may and probably do occur,  their contribution to the expression of the allo- 
geneic effect is  negligible.  Secondly, the  available  evidence argues  against  a 
significant, if any, role for interaction Ia, i.e.  the rejection reaction of T  lym- 
phocytes of the unprimed (donor) population by T lymphocytes isologous to the 
primed B  cell population. This conclusion is based on the following observa- 
tions:  (a)  the  transfer  of  immunologically incompetent  allogeneic lymphoid 
cells,  irrespective of numbers, fails to elicit enhanced antibody production in 
primed  hosts  which  are  capable  of recognizing and  rejecting such  cells  (1); 
(3)  transfer  of parental  lymphoid cells  elicits  an  allogeneic effect in primed 
F1 hybrid recipients which are genetically incapable of mounting a reciprocal 
rejection reaction (3) ; (c) no enhanced antibody production occurs after trans- 
fer  of primed  lymphoid cells  into  allogeneic irradiated  recipients,  a  circum- 
stance in which the transferred cells react against a host that has been rendered 
incapable of developing a rejection response (2). 
Having eliminated considerations of the interactions above, we are left with 462  CELL  INTERACTIONS  IN  ALLOGENEIC  EFFECT 
the  remaining  possibilities  as  represented schematically in  Fig.  5.  The  allo- 
geneic effect, in addition to enhancing antibody production, may also have a 
similar influence on cell-mediated immune responses. Evidence for this is de- 
rived from recent studies in which the highly fatal course of acute lymphocytic 
leukemia  (L2C)  in inbred strain  2  guinea pigs was  significantly altered after 
induction of a transient GVI-I reaction (10, 11). Since detailed studies of specific 
immunity to this particular leukemia have demonstrated  that it is predomi- 
nantly, if not solely, a cell-mediated immunity (12), it is possible that the pro- 
tection observed during the allogeneic effect reflects enhancement of cell-medi- 
ated immunity. Moreover, recent experiments utilizing a more direct approach 
FIG. 5. 
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Cellular interactions  in the allogeneic  effect  II. See text of Discussion for explanation. 
to this question have demonstrated that delayed hypersensitivity reactions in 
guinea pigs can be significantly augmented by the induction of transient GVH 
reactions3 Hence, interaction I between donor and host T  lymphocytes appears 
to have an enhancing effect on subsequent functions of the  latter.  Although 
this implies, on the surface, that the same mechanism may operate to increase 
the  antibody responses  of  the primed  B  15anphocyte poFulation,  i.e.  by  en- 
hancing in some way the interaction III between isologous T and B lymphocytes 
of the primed  cell population,  the  results presented in  this  paper  as well  as 
earlier observations in guinea pigs and mice (1-3)  as discussed above are not 
consistent with this interpretation. 
In the present study, we have shown that, indeed, depletion of the isologous 
T l}maphocytes from the primed cell population does not prevent the expression 
of the allogeneic effect on antibody responses of the B lymphocyte population. 
The efficacy of T  cell depletion by anti-0 serum and complement in these ex- 
periments  is  reflected by  the  abrogation  of  the  anti-DNP  response  of  such 
2  Elgenbein, G., W. E. Paul, and I. Green. Unpublished observations. DAVID It.  KATZ AND  DAVID P.  OSBORNE~ JR.  463 
cells to the homologous DNP-KLH conjugate. Moreover, it is most likely that 
any T  cells bearing 0 determinants in low density and thereby escaping com- 
plement-induced  cytolysis were  rapidly removed by phagocytic cells  of  the 
reticuloendothelial system in vivo after intravenous transfer  (C.  S.  Henney 
and J. D. Stobo, personal communication). A similar result has been  recently 
reported by Kreth and Williamson (13). These observations are,  furthermore, 
consistent with and explain the ability to elicit secondary anti-DNP responses 
with DNP-copolymer of D-glutamic acid  and D-lysine  (D-GL).  As  discussed 
earlier (7), it is presumed, and there is evidence for,  3 the notion that D-GL does 
not stimulate an effective T  cell  helper function. It  appears,  therefore, that 
with respect  to  the  allogeneic effect on  antibody production,  interactions I 
and III of Fig. 5 play a negligible role. 
This leaves one remaining interaction (II),  namely that of the reaction of 
the  foreign  T  lymphocyte  against  the  primed  B  lymphocyte,  to  consider. 
Indeed, as we have shown here, it is this interaction which is the most crucial 
in  the  phenomenon.  Since  the  precise  nature  of  cellular events  during  this 
interaction is undefined, we  can only speculate as to how it might result in 
increased  antibody  production:  (a)  direct  membrane-membrane  interaction 
between  the  two  cells  occurring,  of  course,  under  limiting circumstances in 
which  the  B  lymphocyte is  not killed may stimulate increased proliferation 
and/or metabolic activity of the latter.  (b)  Release of nonspecific stimulatory 
factors from the T  lymphocyte in conditions favored by the intimate spatial 
relationship may markedly increase the magnitude and/or efficiency of the B 
cell response to antigen. (c) A concomitant effect mediated by the occurrence 
of both direct membrane-membrane contact and the release of T  cell-produced 
factors capable of influencing the response of B cells to antigen may occur. 
As discussed in the preceding paper (2) and at length elsewhere (7a, 14),  ~ it 
should be emphasized that, in circumstances of potent T  cell activation such 
as the allogeneic effect, antibody production may be diminished rather than 
increased as a consequence of, perhaps, the very same mechanism(s) enumerated 
above depending on the extent of the interaction. It is possible that elucidation 
of  the  above  alternatives  in  the  allogeneic effect phenomenon may provide 
important insight into the critical events of cell stimulation by antigen. 
SUMMARY 
Experimental  conditions  have  been  established  for  the  elicitation  of  an 
allogeneic  effect  on  the  adoptive  transfer  secondary  anti-2,4-dinitrophenyl 
(DNP)  antibody  response  in  mice.  Thus,  spleen  cells  from  DNP-keyhole 
limpet hemocyanin (KLH)-primed mice manifest good secondary anti-DNP 
3 Katz, D. H., W. E. Paul, and B. Benacerraf. 1972. Carrier function in antihapten antibody 
responses. VI. Establishment of experimental conditions for either inhibitory or enhancing 
influences of carrier-specific cells on antibody production. Manuscript submitted. 464  CELL  INTEI~.ACTIONS  IN  ALLOGENEIC  EFFECT 
responses  to  a  challenge  with  DNP-KLH,  but  not with  DNP-bovine gamma 
globulin  (BGG),  after  adoptive  transfer  to  irradiated  syngeneic  recipients. 
However, a  good adoptive transfer secondary anti-DNP response of such cells 
can be elicited with DNP-BGG when a  second transfer of allogeneic lymphoid 
cells,  in appropriate  numbers,  is  carried out 24 hr before secondary challenge. 
The advantage  to this  system is that  the DNP-primed  cell population  as well 
as  the  population  of allogeneic  lymphoid  cells  are  accessible  to  experimental 
manipulation such that the T  lymphocytes of one or the other can be removed. 
Utilizing this model,  we have  established  that  the allogeneic effect on anti- 
body production can operate on a  population of primed B  lymphocytes which 
have  been  depleted  of  their  isologous  T  lymphocytes by in  vitro  incubation 
with anti-0 serum plus complement. The potential cellular interactions involved 
in  the mechanism of this  phenomenon  are  considered  and  discussed  in detail. 
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